EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Next-generation sequencing for cytomegalovirus genotypic antiviral resistance testing

Heba H Mostafa iD

Journal of Clinical Microbiology · 19.12.2023 · 61 (12)

DOI: 10.1128/jcm.01302-23 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Microbiology, erschienen am 19.12.2023. Verfasst von Heba H Mostafa. Beteiligte Einrichtung: Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine , Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sanger-based sequencing has long served as the gold standard for detecting cytomegalovirus (CMV) resistance mutations. However, next-generation sequencing (NGS) offers a highly multiplexed and sensitive approach. Clinical implementation of NGS-antiviral resistance testing requires thorough validation. In this issue of the Journal of Clinical Microbiology, M. A. Mallory, W. C. Hymas, K. E. Simmon, M. T. Pyne, et al. (J Clin Microbiol 61:e00829-23, 2023, https://doi.org/10.1128/jcm.00829-23 ) detail a validation of a targeted NGS-based assay for multiple genomic regions that confer resistance to CMV antivirals and share their bioinformatics analysis and reporting pipeline. This validation can serve as guidance for laboratories wishing to develop similar methodologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusCytomegalovirus InfectionsHumansHigh-Throughput Nucleotide SequencingDrug Resistance, ViralAntiviral AgentsMutation

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine , Baltimore, Maryland, USA.

ORCID-Profile: Heba H Mostafa

Zitieren

APA

Mostafa, H. H. (2023). Next-generation sequencing for cytomegalovirus genotypic antiviral resistance testing. Journal of Clinical Microbiology, 61(12). https://doi.org/10.1128/jcm.01302-23

Vancouver

Mostafa HH. Next-generation sequencing for cytomegalovirus genotypic antiviral resistance testing. Journal of Clinical Microbiology. 2023;61(12). doi:10.1128/jcm.01302-23

BibTeX
@article{Mostafa2023,
  author = {Mostafa, Heba H},
  title = {Next-generation sequencing for cytomegalovirus genotypic antiviral resistance testing},
  journal = {Journal of Clinical Microbiology},
  year = {2023},
  volume = {61},
  number = {12},
  doi = {10.1128/jcm.01302-23}
}
Kostenlos starten →